Fulvestrant plus targeted agents versus fulvestrant alone for treatment of hormone-receptor positive advanced breast cancer progressed on previous endocrine therapy: a meta-analysis of randomized controlled trials
Crossref DOI link: https://doi.org/10.1007/s12282-017-0770-3
Published Online: 2017-03-21
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lin, Wen-Zhao
Xu, Qi-Ni
Wang, Hong-Biao
Li, Xu-Yuan
License valid from 2017-03-21